Grennady Wirjanata
Rocklands Drive
Casuarina, NT 0810, Australia
Casuarina, NT 0810, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Antimalarial drug artemisinin stabilizes PfRACK1 binding to the ribosome.
Journal: Structure (London, England : 1993)
Published: December 13, 2024
On-target, dual aminopeptidase inhibition provides cross-species antimalarial activity.
Journal: mBio
Published: May 08, 2024
Sterile protection against P. vivax malaria by repeated blood stage infection in the Aotus monkey model.
Journal: Life science alliance
Published: December 13, 2023
Identification and structural validation of purine nucleoside phosphorylase from Plasmodium falciparum as a target of MMV000848.
Journal: The Journal of biological chemistry
Published: September 30, 2023
Identification of an inhibitory pocket in falcilysin provides a new avenue for malaria drug development.
Journal: Cell chemical biology
Published: March 29, 2023
Short tandem repeat polymorphism in the promoter region of cyclophilin 19B drives its transcriptional upregulation and contributes to drug resistance in the malaria parasite Plasmodium falciparum.
Journal: PLoS pathogens
Published: August 26, 2022
The antimalarial MMV688533 provides potential for single-dose cures with a high barrier to Plasmodium falciparum parasite resistance.
Journal: Science translational medicine
Published: January 15, 2021
Longitudinal ex vivo and molecular trends of chloroquine and piperaquine activity against Plasmodium falciparum and P. vivax before and after introduction of artemisinin-based combination therapy in Papua, Indonesia.
Journal: International journal for parasitology. Drugs and drug resistance
Published: December 03, 2020
Molecular surveillance over 14 years confirms reduction of Plasmodium vivax and falciparum transmission after implementation of Artemisinin-based combination therapy in Papua, Indonesia.
Journal: PLoS neglected tropical diseases
Published: October 27, 2019
3,3'-Disubstituted 5,5'-Bi(1,2,4-triazine) Derivatives with Potent in Vitro and in Vivo Antimalarial Activity.
Journal: Journal of medicinal chemistry
Published: February 05, 2019
Last Updated: 09/26/2026